scispace - formally typeset
S

Silvano Sozzani

Researcher at Sapienza University of Rome

Publications -  352
Citations -  47443

Silvano Sozzani is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Chemokine & Chemokine receptor. The author has an hindex of 98, co-authored 335 publications receiving 43598 citations. Previous affiliations of Silvano Sozzani include University of Turin & Brescia University.

Papers
More filters
Journal ArticleDOI

Chemokines as relay signals in human dendritic cell migration: serum amyloid A kicks off chemotaxis.

TL;DR: The authors show that the SAA1α isoform of serum amyloid A (SAA), which is an acute phase protein upregulated in inflammation and shown to chemoattract some leukocyte subsets, is also able to chemeattract monocyte‐derived immature dendritic cells (DCs), providing evidence that proposes a new level of regulation of leukocytes migration.
Journal Article

Cytokine regulation of monocyte recruitment.

TL;DR: A better understanding of the regulation and function of TAM may provide a less empirical basis of or rational design of therapeutic approaches, as vividly illustrated by the antitumor activity of i.p. in IFN ovarian cancer patients with minimal residual disease resistant to chemotherapy.
Journal ArticleDOI

Impairment of dendritic cell functions in patients with adaptor protein-3 complex deficiency.

TL;DR: Analysis of monocyte-derived and pDC-related functions of blood-circulating mononuclear cells revealed reduced interferon-α secretion in response to herpes simplex virus-1 (HSV-1), whereas granzyme-B induction upon IL-3/IL-10 stimulation was normal and T-cell costimulatory activity was lower in patients, suggesting that function and maturation of DCs is abnormal in patients with HPS2.
Journal ArticleDOI

The immune receptor CD300e negatively regulates T cell activation by impairing the STAT1-dependent antigen presentation.

TL;DR: It is demonstrated that the ligation of CD300e in monocytes hampers the expression of the human leukocyte antigen (HLA) class II, affecting its synthesis, and argues against the possibility that this molecule should be considered an activating immune receptor sensu stricto.